Cheng-Qiong Wang

404 total citations
21 papers, 316 citations indexed

About

Cheng-Qiong Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Cheng-Qiong Wang has authored 21 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 5 papers in Immunology. Recurrent topics in Cheng-Qiong Wang's work include Lung Cancer Research Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Pleural and Pulmonary Diseases (5 papers). Cheng-Qiong Wang is often cited by papers focused on Lung Cancer Research Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Pleural and Pulmonary Diseases (5 papers). Cheng-Qiong Wang collaborates with scholars based in China and Thailand. Cheng-Qiong Wang's co-authors include Zheng Xiao, Jihong Feng, Nana Li, Fushan Tang, Shanshan Hu, Xiaofei Li, Yuan Jiang, Xiaofan Chen, Jie Ding and Xue Xiao and has published in prestigious journals such as Journal of Ethnopharmacology, Medicine and Oncotarget.

In The Last Decade

Cheng-Qiong Wang

21 papers receiving 314 citations

Peers

Countries citing papers authored by Cheng-Qiong Wang

Since Specialization

Citations

This map shows the geographic impact of Cheng-Qiong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng-Qiong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng-Qiong Wang more than expected).

Fields of papers citing papers by Cheng-Qiong Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng-Qiong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng-Qiong Wang. The network helps show where Cheng-Qiong Wang may publish in the future.

Co-authorship network of co-authors of Cheng-Qiong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng-Qiong Wang. A scholar is included among the top collaborators of Cheng-Qiong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng-Qiong Wang. Cheng-Qiong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis 2023 ·Phytomedicine ·Cheng-Qiong Wang, (unknown), Hong Jiang, (unknown), Yan Zhang, (unknown), Fei She, (unknown), Lin Zhan, Jihong Feng, (unknown), Xue Xiao, Xiaofan Chen, Zheng Xiao	2
2	The intrapleural administration with thymic peptides in malignant pleural effusion: A clustered systematic review and meta-analysis 2022 ·International Immunopharmacology ·Cheng-Qiong Wang, (unknown), Xiaofan Chen, Hong Jiang, Xuemei Yang, (unknown), Shuguang Li, Ping Yang, Lin Zhan, Rong Chen, Jihong Feng, Xue Xiao, Zheng Xiao	1
3	Intrapleural Perfusion With Staphylococcal Enterotoxin C for Malignant Pleural Effusion: A Clustered Systematic Review and Meta-Analysis 2022 ·Frontiers in Medicine ·Hong Jiang, Xuemei Yang, Cheng-Qiong Wang, (unknown), Jun Huang, Jihong Feng, Xiaofan Chen, (unknown), Lin Zhan, Xue Xiao, Zheng Xiao	1
4	Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis 2021 ·Frontiers in Oncology ·Cheng-Qiong Wang, (unknown), Min He, (unknown), Hong Jiang, (unknown), (unknown), Lin Zhan, (unknown), Jihong Feng, Xue Xiao, Xiaofan Chen, Zheng Xiao	5
5	The Optimal Adjuvant Strategy of Aidi Injection With Gemcitabine and Cisplatin in Advanced Non–small Cell Lung Cancer: A Meta-analysis of 70 Randomized Controlled Trials 2021 ·Frontiers in Pharmacology ·Cheng-Qiong Wang, (unknown), (unknown), Hong Jiang, Jun Huang, Yuan Jiang, Shanshan Hu, (unknown), Shiyu Liu, (unknown), Jihong Feng, Xue Xiao, Xiaofei Li, Zheng Xiao	20
6	Household financial burden among multidrug-resistant tuberculosis patients in Guizhou province, China 2020 ·Medicine ·(unknown), Edward McNeil, (unknown), (unknown), (unknown), Cheng-Qiong Wang, Huijuan Chen, Virasakdi Chongsuvivatwong	23
7	Clinical efficacy and safety of aidi injection combination with vinorelbine and cisplatin for advanced non–small-cell lung carcinoma: A systematic review and meta-analysis of 54 randomized controlled trials 2020 ·Pharmacological Research ·Zheng Xiao, Yuan Jiang, Cheng-Qiong Wang, Shanshan Hu, (unknown), Xiaofan Chen, Jun Huang, (unknown), Yuhong Tang, Yuhe Wang, (unknown), Jihong Feng, Xue Xiao, Xiaofei Li	24
8	Intrathoracic infusion therapy with Lentinan and chemical irritants for malignant pleural effusion: a systematic review and meta-analysis of 65 randomized controlled trials 2020 ·Phytomedicine ·Zheng Xiao, Yuan Jiang, Xiaofan Chen, Cheng-Qiong Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Shanshan Hu, (unknown), (unknown), Yuhong Tang, Jihong Feng, Xue Xiao	11
9	Clinical efficacy and safety of synthetic thymic peptides with chemotherapy for non-small cell lung cancer in China: A systematic review and meta-analysis of 27 randomized controlled trials following the PRISMA guidelines 2019 ·International Immunopharmacology ·(unknown), Zheng Xiao, Cheng-Qiong Wang, Yuan Jiang, (unknown), Shanshan Hu, (unknown), Yuhong Tang, (unknown), Tao Zhang, Xian‐Tao Zeng, Jihong Feng, Xue Xiao	11
10	Clinical Efficacy and Safety of Tanreqing Injection for Pulmonary Infection in Patients with Tuberculosis: A Meta-Analysis 2018 ·The Journal of Alternative and Complementary Medicine ·(unknown), Ling Chen, Cheng-Qiong Wang, Jianbo Yue, Yuqin Li, (unknown), Yang Yuan, (unknown), Zheng Xiao	16
11	Clinical Efficacy and Safety of Aidi Injection Plus Docetaxel‐Based Chemotherapy in Advanced Nonsmall Cell Lung Cancer: A Meta‐Analysis of 36 Randomized Controlled Trials 2018 ·Evidence-based Complementary and Alternative Medicine ·Zheng Xiao, Cheng-Qiong Wang, Lianhong Li, Xuemei Tang, Nana Li, Jing Li, (unknown), Qihai Gong, Fushan Tang, Jihong Feng, Xiaofei Li	16
12	The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials 2018 ·Journal of Immunology Research ·Zheng Xiao, Cheng-Qiong Wang, (unknown), Nana Li, (unknown), Yuzhi Wang, (unknown), Hongsong Yu, Chengwen Li, Xian‐Tao Zeng, Ling Chen, (unknown), Jihong Feng	7
13	Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines 2018 ·Journal of Ethnopharmacology ·Zheng Xiao, Cheng-Qiong Wang, (unknown), Shanshan Hu, Yuan Jiang, (unknown), Nana Li, Jihong Feng, Fushan Tang, Xiaofan Chen, Jie Ding, (unknown), Yuhe Wang, Xiaofei Li	44
14	Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non–small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials 2018 ·Cytotherapy ·Zheng Xiao, Cheng-Qiong Wang, Jihong Feng, (unknown), Yuzhi Wang, Nana Li, (unknown), Shiyu Liu, (unknown), Chengwen Li, Bin Ma, Jie Ding, (unknown)	10
15	Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials 2018 ·International Immunopharmacology ·Zheng Xiao, Cheng-Qiong Wang, (unknown), Nana Li, Shiyu Liu, (unknown), Yuzhi Wang, Jihong Feng, (unknown), Ling Chen, Bin Ma, (unknown), Xian‐Tao Zeng, Chengwen Li, Jie Ding	20
16	Clinical efficacy and safety of sodium cantharidinate plus chemotherapy in non-small-cell lung cancer: A systematic review and meta-analysis of 38 randomized controlled trials 2018 ·Journal of Clinical Pharmacy and Therapeutics ·Zheng Xiao, Cheng-Qiong Wang, (unknown), Shanshan Hu, Yali Chen, (unknown), Jihong Feng, Shiyu Liu, Ling Chen, Jie Ding, Qihai Gong, Fushan Tang, Hui Liu, Xiaofei Li	4
17	Can Aidi injection improve overall survival in patients with non-small cell lung cancer? A systematic review and meta-analysis of 25 randomized controlled trials 2018 ·Complementary Therapies in Medicine ·Zheng Xiao, Cheng-Qiong Wang, Rui Zhou, Shanshan Hu, (unknown), Jihong Feng, (unknown), Shiyu Liu, (unknown), Jie Ding, Qihai Gong, Fushan Tang, Xiaofei Li	22
18	Can Aidi injection alleviate the toxicity and improve the clinical efficacy of radiotherapy in lung cancer? 2016 ·Medicine ·Zheng Xiao, Rui Liang, Cheng-Qiong Wang, (unknown), Nana Li, (unknown), Fushan Tang, Ling Chen, Hu Ma	20
19	Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines 2016 ·Medicine ·Zheng Xiao, Cheng-Qiong Wang, (unknown), Nana Li, Jing Li, (unknown), (unknown), Jie Ding, (unknown)	21
20	Has aidi injection the attenuation and synergistic efficacy to gemcitabine and cisplatin in non-small cell lung cancer? A meta-analysis of 36 randomized controlled trials 2016 ·Oncotarget ·Zheng Xiao, Cheng-Qiong Wang, Chen Ling, Xuemei Tang, Lianhong Li, Nana Li, Jing Li, Qihai Gong, Fushan Tang, Jihong Feng, Xiaofei Li	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact